Key result
Bioinformatics analysis and in vitro validation identified Socs3, Cxcl1, Il1b, and Mmp9 as pivotal angiogenesis-related hub genes with strong diagnostic potential (AUC 0.959-1.0) for myocardial ischemia-reperfusion injury.
Why the study?
Angiogenesis plays a protective role in myocardial ischemia-reperfusion injury (MIRI), but therapeutic targeting of associated genes remains constrained.
Population
Two mouse heart I/R expression datasets (GSE61592 and GSE83472) and human cardiac microvascular endothelial cells
Design
Bioinformatics analysis with in vitro experimental validation
Authors
Loading...
Hypothesis-generating for MIRI gene targets; leaves open clinical translation pending validation.
Effect estimate: AUC 1 for Socs3, Il1b, Mmp9; AUC 0.959 for Cxcl1
p-value: p=<0.001
Socs3, Cxcl1, Il1b, and Mmp9 are key angiogenesis-related genes upregulated in myocardial ischemia-reperfusion injury, offering potential diagnostic biomarkers and therapeutic targets.
Wu et al. (2024) studied Myocardial ischemic reperfusion injury (MIRI) (n=14). Myocardial ischemia-reperfusion injury vs. Sham/Control was evaluated on Diagnostic efficacy (AUC) of hub genes for MIRI (AUC 1 for Socs3, Il1b, Mmp9; AUC 0.959 for Cxcl1, p=<0.001). Bioinformatics analysis and in vitro validation identified Socs3, Cxcl1, Il1b, and Mmp9 as pivotal angiogenesis-related hub genes with strong diagnostic potential (AUC 0.959-1.0) for myocardial ischemia-reperfusion injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: